Van Hulzen Asset Management, LLC - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 88 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Van Hulzen Asset Management, LLC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$4,000
-42.9%
18,2000.0%0.00%
-100.0%
Q4 2021$7,000
-36.4%
18,2000.0%0.00%
-50.0%
Q3 2021$11,000
-52.2%
18,2000.0%0.00%
-50.0%
Q1 2021$23,00018,2000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q1 2022
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 432,503$554,0000.09%
MONECO Advisors, LLC 35,000$45,0000.02%
Purus Wealth Management, LLC 15,000$19,0000.02%
Renaissance Technologies 8,454,364$10,822,0000.01%
LMR Partners LLP 390,864$500,0000.01%
ExodusPoint Capital Management, LP 595,459$762,0000.01%
LINCOLN CAPITAL CORP 12,000$15,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 264,500$339,0000.01%
HRT FINANCIAL LP 347,816$445,0000.01%
FIRST MIDWEST BANK TRUST DIVISION 25,000$32,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders